TuHURA Biosciences HURA
NASDAQ HURA
$2.01 -0.08 (-3.60%)
At close: Oct 22, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Net Margin (2025)

Updated

Analysis

TuHURA Biosciences (HURA) Net Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.83%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 21.27%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.30%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -134.51%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -1.65%
10 TuHURA Biosciences 127.67 Mn 114.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -14,641.30%
Mar 31, 2025 -14,894.79%
API Access

TuHURA Biosciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=HURA&period=max&api_key=YOUR_API_KEY